However, a study has shown that a prevalent CXCL12 gene polymorphism linked to heightened CXCL12 production predisposes patients with chronic myeloproliferative disorders to arterial thrombosis, potentially due to the influence of VEGF (27). The gene discussed is CXCL12; the disease is Arterial thrombosis.